Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2020

01-12-2020 | Mastectomy | Research article

The psychosocial determinants of quality of life in breast cancer survivors: a scoping review

Authors: Michael G. Culbertson, Kathleen Bennett, Catherine M. Kelly, Linda Sharp, Caitriona Cahir

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

Breast cancer care today involves state-of-the-art biomedical treatment but can fail to address the broader psychosocial and quality-of-life (QoL) issues associated with the transition to breast cancer survivorship. This scoping review examines the evidence on the influence of psychosocial determinants on QoL in breast cancer survivors.

Methods

Scoping review methodology was used to: (1) identify the research question(s); (2) identify relevant studies; (3) undertake study selection; (4) extract data; (5) collate, summarise and report the results.

Results

A total of 33 studies met the inclusion criteria. The majority of studies were conducted in the US (n = 22, 67%) and were mainly cross-sectional (n = 26, 79%). Sixteen psychosocial determinants of QoL were identified. Social support (n = 14, 42%), depression (n = 7, 21%) and future appraisal and perspective (n = 7, 21%) were the most frequently investigated determinants. Twelve different QoL measures were used. A range of different measurement tools were also used per psychosocial determinant (weighted average = 6). The 14 studies that measured the influence of social support on QoL employed 10 different measures of social support and 7 different measures of QoL. In general, across all 33 studies, a higher level of a positive influence and a lower level of a negative influence of a psychosocial determinant was associated with a better QoL e.g. higher social support and lower levels of depression were associated with a higher/better QoL. For some determinants such as spirituality and coping skills the influence on QoL varied, but these determinants were less commonly investigated.

Conclusion

Consensus around measures of QoL and psychological determinants would be valuable and would enable research to determine the influence of psychosocial determinants on QoL adequately. Research in other healthcare settings beyond the US is required, in order to understand the influence of organisation and follow-up clinical and supportive care on psychosocial determinants and QoL and to improve the quality of care in breast cancer survivors.
Appendix
Available only for authorised users
Literature
1.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.PubMedPubMedCentralCrossRef
2.
Sharp L, Deady S, Gallagher P, Molcho M, Pearce A, Alforque Thomas A, et al. The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer. 2014;14(1):767.PubMedPubMedCentralCrossRef
3.
4.
Bell K, Ristovski-Slijepcevic S. Cancer survivorship: why labels matter. J Clin Oncol. 2013;31(4):409–11.PubMedCrossRef
5.
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(1):34–45.CrossRef
6.
Keesing S, Rosenwax L, McNamara B. A call to action: The need for improved service coordination during early survivorship for women with breast cancer and partners. Women Health. 2019;59(4):406–19.PubMedCrossRef
7.
Costanzo ES, Lutgendorf SK, Mattes ML, Trehan S, Robinson CB, Tewfik F, et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer. 2007;97(12):1625–31.PubMedPubMedCentralCrossRef
8.
Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30(11):1215–20.PubMedCrossRef
9.
Institute of Medicine Committee on Psychosocial Services to Cancer Patients/Families in a Community S. The National Academies Collection: Reports funded by National Institutes of Health. In: Adler NE, Page AEK, editors. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington (DC): National Academies Press (US) National Academy of Sciences; 2008.
10.
11.
Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2014;1(5):343–50.PubMedCrossRef
12.
Bloom JR, Petersen DM, Kang SH. Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology. 2007;16(8):691–706.PubMedCrossRef
13.
Carver CS, Smith RG, Petronis VM, Antoni MH. Quality of life among long-term survivors of breast cancer: different types of antecedents predict different classes of outcomes. Psycho-Oncology. 2006;15(9):749–58.PubMedCrossRef
14.
Doege D, Thong MS, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, et al. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Res Treat. 2019;175(2):499–510.PubMedCrossRef
15.
Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L. Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res. 2005;14(2):361–71.PubMedCrossRef
16.
Bower JE, Meyerowitz BE, Desmond KA, Bernaards CA, Rowland JH, Ganz PA. Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors. Ann Behav Med. 2005;29(3):236–45.PubMedCrossRef
17.
Mols F, Vingerhoets AJJM, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005;41(17):2613–9.PubMedCrossRef
18.
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143.PubMedPubMedCentralCrossRef
19.
Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.CrossRef
20.
21.
Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997;15(3):974–86.PubMedCrossRef
22.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.PubMedCrossRef
23.
Goyal NG, Levine BJ, Van Zee KJ, Naftalis E, Avis NE. Trajectories of quality of life following breast cancer diagnosis. Breast Cancer Res Treat. 2018;169(1):163–73.PubMedPubMedCentralCrossRef
24.
Deshields T, Tibbs T, Fan M-y, Taylor M. Differences in patterns of depression after treatment for breast cancer. Psycho-Oncology. 2006;15(5):398–406.PubMedCrossRef
25.
Paek M-S, Ip EH, Levine B, Avis NE. Longitudinal reciprocal relationships between quality of life and coping strategies among women with breast cancer. Ann Behav Med. 2016;50(5):775–83.PubMedCrossRef
26.
Janz NK, Friese CR, Li Y, Graff JJ, Hamilton AS, Hawley ST. Emotional well-being years post-treatment for breast cancer: prospective, multi-ethnic, and population-based analysis. J Cancer Surviv. 2014;8(1):131–42.PubMedCrossRef
27.
Bellizzi KM, Smith AW, Reeve BB, Alfano CM, Bernstein L, Meeske K, et al. Posttraumatic growth and health-related quality of life in a racially diverse cohort of breast cancer survivors. J Health Psychol. 2010;15(4):615–26.PubMedCrossRef
28.
Durá-Ferrandis E, Mandelblatt JS, Clapp J, Luta G, Faul L, Kimmick G, et al. Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: Calgb protocol 369901 (alliance). Psycho-Oncology. 2017;26:1914.PubMedPubMedCentralCrossRef
29.
Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner S, Waldmann A, et al. Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship--a multi-regional population-based study. Psychooncology. 2014;23(5):547–54.PubMedCrossRef
30.
Taylor T, Huntley E, Sween J, Makambi K, Mellman T, Williams C, et al. An exploratory analysis of fear of recurrence among African-American breast cancer survivors. Int J Behav Med. 2012;19(3):280–7.PubMedPubMedCentralCrossRef
31.
Ho SSM, So WKW, Leung DYP, Lai ETL, Chan CWH. Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. Eur J Oncol Nurs. 2013;17(6):877–82.PubMedCrossRef
32.
Sammarco A, Konecny LM. Quality of life, social support, and uncertainty among Latina breast cancer survivors. Oncol Nurs Forum. 2008;35(5):844–9.PubMedCrossRef
33.
Ashing-Giwa KT, Lim JW. Predicting physical quality of life among a multiethnic sample of breast cancer survivors. Qual Life Res. 2010;19(6):789–802.PubMedCrossRef
34.
Cheng H, Sit JW, Chan CW, So WK, Choi KC, Cheng KK. Social support and quality of life among Chinese breast cancer survivors: findings from a mixed methods study. Eur J Oncol Nurs. 2013;17(6):788–96.PubMedCrossRef
35.
DiSipio T, Hayes S, Newman B, Janda M. What determines the health-related quality of life among regional and rural breast cancer survivors? Aust N Z J Public Health. 2009;33(6):534–9.PubMedCrossRef
36.
Huang C-Y, Hsu M-C. Social support as a moderator between depressive symptoms and quality of life outcomes of breast cancer survivors. Eur J Oncol Nurs. 2013;17(6):767–74.PubMedCrossRef
37.
Lewis JA, Manne SL, DuHamel KN, Vickburg SM, Bovbjerg DH, Currie V, et al. Social support, intrusive thoughts, and quality of life in breast cancer survivors. J Behav Med. 2001;24(3):231–45.PubMedCrossRef
38.
Northouse LL, Caffey M, Deichelbohrer L, Schmidt L, Guziatek-Trojniak L, West S, et al. The quality of life of African American women with breast cancer. Res Nurs Health. 1999;22(6):449–60.PubMedCrossRef
39.
Pedro LW. Quality of life for long-term survivors of cancer: influencing variables. Cancer Nurs. 2001;24(1):1–11.PubMedCrossRef
40.
Edib Z, Kumarasamy V, binti Abdullah N, Rizal AM, Al-Dubai SAR. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outcomes. 2016;14(1):26.PubMedPubMedCentralCrossRef
41.
Avis NE, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol. 2005;23(15):3322–30.PubMedCrossRef
42.
Begovic-Juhant A, Chmielewski A, Iwuagwu S, Chapman LA. Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol. 2012;30(4):446–60.PubMedCrossRef
43.
Cheng ASK, Lau LOC, Ma YNH, Ngai RH, Fong SSL. Impact of cognitive and psychological symptoms on work productivity and quality of life among breast cancer survivors in Hong Kong. Hong Kong J Occup Ther. 2016;28(1):15–23.PubMedPubMedCentralCrossRef
44.
Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manag. 2008;35(6):644–55.CrossRef
45.
Akechi T, Momino K, Miyashita M, Sakamoto N, Yamashita H, Toyama T. Anxiety in disease-free breast cancer patients might be alleviated by provision of psychological support, not of information. Jpn J Clin Oncol. 2015;45(10):929–33.PubMedCrossRef
46.
Kessler TA. Contextual variables, emotional state, and current and expected quality of life in breast cancer survivors. Oncol Nurs Forum. 2002;29(7):1109–16.PubMedCrossRef
47.
Paek MS, Lim JW. Understanding the stress process of Chinese- and Korean-American breast cancer survivors. J Immigr Minor Health. 2016;18(5):1159–67.PubMedPubMedCentralCrossRef
48.
Manning-Walsh J. Spiritual struggle: effect on quality of life and life satisfaction in women with breast cancer. J Holist Nurs. 2005;23(2):120–40 discussion 41-4.PubMedCrossRef
49.
Wildes KA, Miller AR, de Majors SSM, Ramirez AG. The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of life. Psycho-Oncology. 2009;18(8):831–40.PubMedPubMedCentralCrossRef
50.
Petersen LR, Clark MM, Novotny P, Kung S, Sloan JA, Patten CA, et al. Relationship of optimism-pessimism and health-related quality of life in breast cancer survivors. J Psychosoc Oncol. 2008;26(4):15–32.PubMedCrossRef
51.
Farren AT. Power, uncertainty, self-transcendence, and quality of life in breast cancer survivors. Nurs Sci Q. 2010;23(1):63–71.PubMedCrossRef
52.
Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21(22):4184–93.PubMedCrossRef
53.
Bouskill K, Kramer M. The impact of cancer and quality of life among long-term survivors of breast cancer in Austria. Support Care Cancer. 2016;24(11):4705–12.PubMedCrossRef
54.
Morrill EF, Brewer NT, O'Neill SC, Lillie SE, Dees EC, Carey LA, et al. The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psycho-Oncology. 2008;17(9):948–53.PubMedCrossRef
55.
56.
Edib Z, Kumarasamy V, Abdullah N, Rizal AM, Al-Dubai SAR, Binti Abdullah N. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outcomes. 2016;14:1–10.CrossRef
57.
Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.PubMedCrossRef
58.
Ferrans CE. Development of a quality of life index for patients with cancer. Oncol Nurs Forum. 1990;17(3 Suppl):15–9 discussion 20-1.PubMed
59.
Cantril H. The pattern of human concerns. New Brunswick: Rutgers University Press; 1965.
60.
Sohl SJ, Levine B, Avis NE. Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for early post-treatment breast cancer survivors. Qual Life Res. 2015;24(1):205–12.PubMedCrossRef
61.
Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.PubMedCrossRef
62.
63.
Cohen S., Underwood LG, Gottlieb BH. Social support measurement and intervention: a guide for health and social scientists. 2000. New York.CrossRef
64.
Sarason IG, Sarason BR, Shearin EN, Pierce GR. A brief measure of social support: practical and theoretical implications. J Soc Pers Relat. 1987;4(4):497–510.CrossRef
65.
Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM Jr. Social ties and susceptibility to the common cold. JAMA. 1997;277(24):1940–4.PubMedCrossRef
66.
Northouse LL. Social support in patients’ and husbands’ adjustment to breast cancer. Nurs Res. 1988;37(2):91–5.PubMedCrossRef
67.
Smilkstein G. The family APGAR: a proposal for family function test and its use by physicians. J Fam Pract. 1978;6(6):1231–9.PubMed
68.
Norbeck JS. Social support: a model for clinical research and application. Adv Nurs Sci. 1981;3(4):43.CrossRef
69.
McElduff P, Boyes A, Zucca A, Girgis A. Supportive Care Needs Survey: A guide to administration, scoring and analysis. Centre for Health Research & Psycho-oncology; 2004.
70.
Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol. 1993;11(4):783–93.PubMedCrossRef
71.
Radloff LS. The CES-D scale:a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef
72.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRef
73.
Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of beck depression inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–97.PubMedCrossRef
74.
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54:1063.PubMedCrossRef
75.
Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4:92.PubMedCrossRef
76.
McCubbin H, Larsen A, Olson D. Family crisis orientated personal evaluation scales (FCOPES). In: McCubbin H, Thompson AI, editors. Family assessment inventories for research and practice; 1987. p. 193–207.
77.
Dunkel-Schetter C, Feinstein LG, Taylor SE, Falke RL. Patterns of coping with cancer. Health Psychol. 1992;11(2):79–87.PubMedCrossRef
78.
Becker H, Stuifbergen A, Oh HS, Hall S. Self-rated abilities for health practices: a health self-efficacy measure. Health Values. 1993;17(5):42–50.
79.
Rosenberg M, Kaplan H. Social psychology of the self-concept. Chicago: Harlan Davidson; 1982.
80.
Cope DG, Olson K, Humenick SS. Self-esteem and the practice of breast self-examination. West J Nurs Res. 1992;14(5):618–31.PubMedCrossRef
81.
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002;24(1):49–58.PubMedCrossRef
82.
Pargament KI, Smith BW, Koenig HG, Perez L. Patterns of positive and negative religious coping with major life stressors. J Sci Study Relig. 1998;37(4):710–24.CrossRef
83.
Holland JC, Kash KM, Passik S, Gronert MK, Sison A, Lederberg M, et al. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Psycho-Oncology. 1998;7(6):460–9.PubMedCrossRef
84.
Scheier MF, Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985;4(3):219–47.PubMedCrossRef
85.
Colligan RC, Offord KP, Malinchoc M, Schulman P, Seligman MEP. CAVEing the MMPI for an optimism-pessimism scale: Seligman's attributional model and the assessment of explantory style. J Clin Psychol. 1994;50:71–95.PubMedCrossRef
86.
Mishel MH. Uncertainty in illness. Image. 1988;20:225–32.
87.
Oberst MT. Appraisal of illness scale: manual for use. Detroit: Wayne State University; 1991.
88.
Barrett EA, Caroselli C. Methodological ponderings related to the power as knowing participation in change tool. Nurs Sci Q. 1998;11(1):17–22.PubMedCrossRef
89.
Reed PG. Self-transcendence scale. Tucson: University of Arizona; 1987.
90.
Hawley ST, Janz NK, Hamilton A, Griggs JJ, Alderman AK, Mujahid M, et al. Latina patient perspectives about informed treatment decision making for breast cancer. Patient Educ Couns. 2008;73(2):363–70.PubMedPubMedCentralCrossRef
91.
Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, et al. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505–11.PubMedCrossRef
92.
Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16–24.PubMedCrossRef
93.
Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.PubMedCrossRef
94.
Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–18.PubMedCrossRef
95.
Devins GM. Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. J Psychosom Res. 2010;68(6):591–602.PubMedCrossRef
96.
Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology. 2006;15(5):407–21.PubMedPubMedCentralCrossRef
97.
Weathers FW, Huska JA, TM. K. PCL-C for DSM-IV. Boston: National Center for PTSD—Behavioral Science Division; 1991.
98.
Mood D, Bickes J. Strategies to enhance self-care in radiation therapy. Oncol Nurs Forum (Supplement). 1989;16:143.
99.
Ashing-Giwa KT, Padilla GV, Tejero JS, Kim J. Breast cancer survivorship in a multiethnic sample: challenges in recruitment and measurement. Cancer. 2004;101(3):450–65.PubMedCrossRef
100.
Ashing-Giwa K, Ganz PA, Petersen L. Quality of life of African-American and white long term breast carcinoma survivors. Cancer. 1999;85(2):418–26.PubMedCrossRef
101.
Olson D. FACES IV and the Circumplex Model: validation study. J Marital Fam Ther. 2011;37(1):64–80.PubMedCrossRef
102.
Mallinger JB, Griggs JJ, Shields CG. Family communication and mental health after breast cancer. Eur J Cancer Care. 2006;15(4):355–61.CrossRef
103.
Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–71.PubMedCrossRef
104.
Ottati A, Feuerstein M. Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv. 2013;7(2):262–73.PubMedCrossRef
105.
Lerner D, Amick BC 3rd, Rogers WH, Malspeis S, Bungay K, Cynn D. The work limitations questionnaire. Med Care. 2001;39(1):72–85.PubMedCrossRef
106.
DiMatteo MR, Hays RD, Gritz ER, Bastani R, Crane L, Elashoff R, et al. Patient adherence to cancer control regimens: scale development and initial validation. Psychol Assess. 1993;5(1):102–12.CrossRef
107.
108.
Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Densitom. 1998;16:139.
109.
Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.PubMedPubMedCentralCrossRef
110.
Hullmann SE, Robb SL, Rand KL. Life goals in patients with cancer: a systematic review of the literature. Psycho-Oncology. 2016;25(4):387–99.PubMedCrossRef
111.
Garchinski CM, DiBiase A-M, Wong RK, Sagar SM. Patient-centered care in cancer treatment programs: the future of integrative oncology through psychoeducation. Future Oncol. 2014;10(16):2603–14.PubMedCrossRef
112.
Gudenkauf LM, Ehlers SL. Psychosocial interventions in breast cancer survivorship care. Breast. 2018;38:1–6.PubMedCrossRef
Metadata
Title
The psychosocial determinants of quality of life in breast cancer survivors: a scoping review
Authors
Michael G. Culbertson
Kathleen Bennett
Catherine M. Kelly
Linda Sharp
Caitriona Cahir
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-07389-w

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue

Case report

Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature

Research article

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma

Research article

Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients

Research article

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial

Research article

Sphingomyelin(d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study

Technical advance

An immunochemistry-based screen for chemical inhibitors of DNA-protein interactions and its application to human CGGBP1
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits